News
Cleo Health Debuts Acute Care OS at HIMSS 2026, Unifying Documentation, Charge Capture, and CDI in a Single AI-Driven Platform
5+ hour, 55+ min ago (591+ words) The ultimate gateway for AI market insights, products, and solutions! The AI Journal provides news, analysis, opinions, and market trends specifically on emerging technologies to ambitious individuals and companies around the world. We equip businesses, governments, and educational institutes with…...
Comfort Keepers Explains Senior Home Care Assistance in Cooper City, FL
4+ hour, 55+ min ago (447+ words) Comfort Keepers of Davie, FL, shares insight on senior home care assistance in Cooper City, FL, and how structured in-home support strengthens daily living, safety, and independence. Families seeking reliable support often prioritize personal care, mobility assistance, medication reminders, and…...
athenahealth at HIMSS 2026: AI and Intelligent Interoperability in Action
3+ hour, 53+ min ago (135+ words) From empowering patients with AI-driven access to their health data, to enabling closed-loop referrals across EHRs, athenahealth's open architecture brings real-time data into clinical workflows athenahealth will hold speaking roles across various sessions at HIMSS: HIMSS attendees are invited to…...
Ayurveda AI: Where Ancient Intelligence Meets Modern Artificial Intelligence
4+ hour, 18+ min ago (464+ words) CureNatural is helping define a new frontier in digital health: Ayurveda AI " the fusion of classical Ayurvedic wisdom with modern artificial intelligence. As healthcare increasingly turns to predictive analytics and precision medicine, Ayurveda offers something technology has struggled to replicate:…...
CORRECTING and REPLACING QuantHealth Achieves Impressive 8x Financial Growth Across Life Sciences Engagements
5+ hour, 37+ min ago (159+ words) TEL AVIV, Israel(BUSINESS WIRE)Please replace the release with the following corrected version due to multiple revisions. In 2025, QuantHealth also established the industry's most advanced clinical trial simulation portfolio nearly doubling its clinical trial simulations to more than 600 trials…...
Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology
7+ hour, 25+ min ago (533+ words) The ultimate gateway for AI market insights, products, and solutions! The AI Journal provides news, analysis, opinions, and market trends specifically on emerging technologies to ambitious individuals and companies around the world. We equip businesses, governments, and educational institutes with…...
NextGen Healthcare to Support Alexander Youth Network with Modern EHR to Enhance Care and Strengthen Outcomes for Children and Young Adults
7+ hour, 23+ min ago (220+ words) New cloud-based technology will help Alexander Youth Network enhance client experience Founded in 1888, Alexander Youth Network provides outpatient, residential, crisis, and community'based behavioral health services. Together with its subsidiaries'The Relatives in Charlotte and Youth Focus in Greensboro, which offer crisis…...
Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD and Announces Duchenne Muscular Dystrophy Investor Event
8+ hour, 58+ min ago (227+ words) " Fast Track designation aims to facilitate development and expedite review of drugs, such as PBGENE-DMD to treat serious conditions like Duchenne muscular dystrophy " " March 17, 2026 virtual webinar to feature expert insights on potential clinical utility of PBGENE-DMD for patients with Duchenne…...
ENHERTU® Granted Priority Review in the U.S. as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer
13+ hour, 28+ min ago (1148+ words) ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca. Data also showed that ENHERTU significantly reduced the risk of disease recurrence or death…...
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
13+ hour, 58+ min ago (441+ words) The giredestrant clinical development program is made up of distinct studies designed to reflect the specific disease biology of each stage of breast cancer. Genentech will continue to advance the clinical development program to identify the people with ER-positive breast…...